Source: Virtual Congress 2021 – Pathogenic progress in airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Abduganieva (Tashkent, Uzbekistan), I. Liverko (Tashkent, Uzbekistan), K. Boboev (Tashkent, Uzbekistan), S. Ahmedov (Tashkent, Uzbekistan). Inherited thrombophilia in the development of thrombotic conditions in patients with COPD. 2387

Member's Comments

No comment yet.

Related content which might interest you: Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Variants  of genes related to cardiovascular disease in patients with pulmonary thromboembolism Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Contribution of thrombophilic genetic factors in development and recurrent manifestation of pulmonary embolism in young patients Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Phenotypic factors as predictors of thrombotic conditionsin patients with chronic obstructive disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Coexistence of cardiovascular diseases in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Inherited thrombophilic risk factors in venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Platelet function in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009 Chronic thromboembolic pulmonary hypertension (CTEPH) and coagulation defects: Before and after treatment Source: International Congress 2017 – PAH and CTEPH Year: 2017 Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J 2014; 44: 951-962 Year: 2014 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006 Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018 Year: 2018 Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD) Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010